AUTM Annual Meeting
The AUTM Annual Meeting gathers together the community of academic technology transfer professionals from around the world.…
Our Seed Fund is investing £1million in Pheno Therapeutics to identify and develop potential new treatments that pr… https://t.co/TgpoBPhAb9
Drug Repurposing for Rare Diseases
LifeArc is a key sponsor at the Drug Repurposing for Rare Diseases conference, which showcases excellence in…
Celebrating the International Day of Women and Girls in Science
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back
LifeArc and Action Medical Research launch funding call for research into rare diseases in children
£1m for translational research projects focussed on children’s rare diseases
LifeArc appoints new Chief Investment Officer (CIO)
Graham Duce appointed to the newly created role of CIO to ensure that we have a sustainable approach to income generation